Please login to the form below

Not currently logged in
Email:
Password:
PMLiVE Top Pharma List

36

Revenue 2017

Xtandi

The Top Pharma List's top 50 pharmaceutical products by global sales ranking is compiled from GlobalData's pharmaceutical revenue figures. Xtandi was produced by Astellas.

NICE changes tack on Sanofi's prostate cancer drug Jevtana

NICE changes tack on Sanofi's prostate cancer drug Jevtana Previously, NICE said that Sanofi had been unable to demonstrate that Jevtana was cost-effective compared to standard treatments such as Johnson &Johnson's Zytiga (abiraterone), Astellas/Medivation's Xtandi (enzalutamide)

Sanofi takeover bid rebuffed by Medivation

Sanofi takeover bid rebuffed by Medivation Medivation has partnered with Astellas to sell prostate cancer drug Xtandi (enzalutamide) for advanced castration-resistant prostate cancer and is also developing the drug for other prostate cancer indications as well ... Sales of Xtandi reached $1.9bn

Astellas: Ten years young

Astellas: Ten years young Its efforts to date in oncology have seen it form a prostate cancer franchise on the back of Eligard (leuprolide acetate) and more recently Xtandi (enzalutamide). ... There it is currently conducting a series of investigations in breast cancer to assess

NICE backs Xtandi but turns down Zytiga

NICE backs Xtandi but turns down Zytiga Astellas and Medivation's pre-chemotherapy prostate cancer drug receives support. UK cost-effectiveness agency NICE has given a boost to Astellas and Medivation's Xtandi, backing its use in ... handing an important advantage to Xtandi as it tries to claw

Astellas’ Xtandi cancer drug rejected by NICE

Astellas’ Xtandi cancer drug rejected by NICE The newly released draft guidance does not recommended Xtandi as a treatment for advanced prostate cancer. ... Xtandi is already NICE-approved for men with metastatic hormone-relapsed prostate cancer, who have already had treatment with

[ Previous 5 results ] 4 5 6 7 8 9 10 11 12 13 [ Next 5 results ]

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Conversis

Conversis is a translation company specialising in translation and localisation for the Life Science and Pharmaceutical industry, with particular focus...

Latest intelligence

Webinar: Usability and UX: You’ve been asked to test...What next?
Thursday 27th June 2019 10am EDT / 3pm BST / 4pm CEST...
Event: EphMRA Annual Conference
We're sponsoring, exhibiting and presenting three papers at this year’s EphMRA Annual Conference in Warsaw, Poland....
Research Partnership and Janssen awarded runner-up in MR Excellence Awards
...

Infographics